When an Organisation’s Purpose Becomes Itself: The NHS Must Rediscover Its Telos

The NHS was one of humanity's greatest ideas. It is now one of Britain's most persistent failures. It failed because it stopped serving patients and started serving itself. Personal ownership, real competition and unconditional solidarity for the blameless are the way back.

When an Organisation’s Purpose Becomes Itself: The NHS Must Rediscover Its Telos

The NHS was conceived as one of humanity’s highest moral advancements: a collective undertaking to stand between ordinary people and the ancient terrors of pain, suffering and premature death. That was its telos, its purpose. It was simple.

In the 78 years since its founding in 1948, that simple idea became an institution, and its purpose became obfuscated under the accumulated layers of bureaucracy, complexity and inaccessibility. What was meant to serve patients is today more preoccupied with its own continuity.

Successive governments have all tried to “fix” the NHS. It has been their political football, but they have rarely scored a goal. The service has been repeatedly reorganised to become more effective and efficient. But what was once just 2.9-5.2% of GDP (1953-2000) now costs 9.9% of GDP. A study published in the Journal of the Royal Society of Medicine using 65 years of data between 1948 to 2012 concluded that centrally led structural change had “no sustained effect on mortality” and that politically led management change appeared to be a “wasteful ineffective practice”. Meanwhile, governments threw record sums at the system, including the National Programme for IT, whose cost estimate rose from £2.3 billion to £12.7 billion before its central version was cancelled. The Public Accounts Committee later described the same IT saga as one of the “worst and most expensive contracting fiascos” in public-sector history.

The bureaucracy has also failed at workforce planning. The NHS now depends heavily on overseas staff. In 2025, the number of non-British citizens in the NHS workforce stood at about 311,000, roughly one in five employees. The King’s Fund has repeatedly warned of continued reliance on international recruitment, particularly from India and the Philippines, and of a concerning rise in nurses joining the register from “red list” countries that can ill afford to lose health professionals. The World Health Organization explicitly discourages active recruitment from countries with the most serious health workforce vulnerabilities.

At home, the picture is no better. The elective waiting list in England stood at 7.22 million cases in January 2026 (cases refers to different conditions/treatments with some patients on multiple waiting lists), with about 2.70 million patients waiting more than 18 weeks and around 123,000 waiting more than a year. Cancer waiting-time performance has deteriorated markedly: in England, the proportion of patients waiting longer than the 62-day standard rose from 11.0% in early 2012 to 33.4% in the second quarter of 2024. UK cancer survival has improved over time, but remains poor by comparison with many peer countries, and the UK is lagging in providing timely and effective care for people who develop cancer or cardiovascular disease. General practice is still working at extraordinary volume: in February 2026 general practice and primary care networks delivered about 31.8 million consultations, but only 44.4% were on the same day and 83.1% were within two weeks. And, in a particularly perverse twist, newly registered nurses have reported struggling to find permanent jobs despite the supposed staffing crisis.

Current debates about the next “fix” include introducing more insurance-based elements into the NHS. These debates often miss the deeper structural problem: any institution that has learned to defend its own continuity will fight to retain the status quo. Proponents of insurance argue that it could bring efficiency, choice and fiscal discipline. Critics warn of a two-tier system, adverse selection, higher administrative costs and the erosion of solidarity. Both sides are trapped in a false binary: defend the NHS as it is, or move toward something resembling American-style insurance. Neither adequately confronts how the current model drifted from its telos, nor how any replacement must consciously guard against the same institutional decay.

Compounding this is a political myth that remains stubbornly intact: that the NHS is simply “free at the point of delivery.” The NHS Constitution is more careful: NHS services are free of charge “except in limited circumstances sanctioned by Parliament”. Those exceptions matter. Prescriptions, dentistry, eye care and even hospital parking can all involve direct costs to patients. Government guidance on hospital parking, for example, requires free parking for some groups but still recognises that charges exist and should be “reasonable” where applied. The rhetoric of “free” care obscures the reality that the NHS has always involved trade-offs, hidden rationing and personal expense.

Drug funding is one of the clearest examples of that hidden rationing. NICE does not simply ask whether a medicine works; its own cost-effectiveness threshold guidance says it assesses value for money through quality-adjusted life years, historically using a standard range of £20,000 to £30,000 per QALY. When NICE says no, its patient guidance on access to treatment confirms that the medicine may still be available privately, or through an individual funding request made by a clinician where circumstances are exceptional. Cross-border variation makes the trade-off starker. NICE decides medicine access in England, while the Scottish Medicines Consortium performs that role in Scotland and other bodies decide for Wales and Northern Ireland. In March 2025, BBC News reported that abiraterone was available in Scotland and Wales for some high-risk prostate-cancer patients whose cancer had not yet spread, while remaining unavailable for that group in England and Northern Ireland, with one English patient spending £20,000 privately. This is not an argument that every medicine should be funded at any price. It is an admission that “free” care can mean a queue, a refusal, an appeal, a private invoice, or a search for treatment somewhere else.

Any serious diagnosis must acknowledge these facts.

The future of the NHS must start with restoring its purpose.

The Noble Idea: Poverty Should Not Mean Death

In the aftermath of depression and world war, Britain resolved that no citizen should be ruined by illness or denied treatment through poverty. The Beveridge Report records that “Disease” was one of the five giant evils to be defeated in post-war reconstruction. Martin Gorsky, Professor in the History of Public Health describes the National Health Service launched in 1948 as a universal, comprehensive service, funded mostly from general taxation and free at the point of use.

This was a noble, even transcendent vision. For the first time, a nation declared that access to healthcare should not be determined by wealth, class or luck. It aligned with the deepest moral instinct: that suffering is an evil to be fought collectively. That idea retains enormous power and remains worth fighting for.

A Fragile Starting Compromise

The comprehensive NHS model was never a universal consensus. It faced resistance from vested interests and from sections of the medical profession. The British Medical Association feared the loss of clinical freedom and the prospect of doctors becoming public employees. Aneurin Bevan’s settlement preserved GPs as self-employed contractors while hospital doctors became salaried employees, with consultants allowed to retain private practice. The familiar line that Bevan “filled their mouths with gold” has endured because it captures the hard political bargain needed to bring consultants into the new service.

The NHS was a hard-fought political settlement, imperfect from the beginning and always in need of vigilance to keep the patient and clinician at its centre.

From Care To Managerialism

Over decades, the NHS has undergone a profound inversion. Clinical vocation has been subordinated to managerial ritual. The 2012 reforms, for example, were supposed to simplify and streamline the NHS; they instead created “considerable complexity and confused accountabilities,” fragmentation and distraction from patient care. In 2025, the government announced the abolition of NHS England, the world’s largest quango, saying the 2012 reorganisation had created “burdensome layers of bureaucracy” and a focus on compliance and box-ticking rather than patient care, value and innovation.

This is not an argument against all management. It is an argument against managerialism: the belief that process, reporting and reorganisation can substitute for judgement, competence and moral seriousness. Targets can sometimes improve performance, but they can also distort clinical behaviour. A study of the 18-week referral-to-treatment standard found evidence of unintended consequences: that targets produced threshold effects, encouraging selective behaviour around the target rather than systemic improvement. In other words, some NHS leaders chose adverse behaviours to hit managerial targets at the expense of safety.

A Thousand Cuts Of Institutional Decay

Mature organisations often shift quietly from service to continuity. Reputation management overtakes mission. Moral thresholds adjust until covering up error, waste or mismanagement becomes normalised. Whistleblowers are treated as threats rather than safeguards.

The Francis Report into Mid Staffordshire remains the defining warning. The Mid Staffordshire Public Inquiry found “appalling suffering” caused by serious board failure, an “insidious negative culture,” a failure to listen to patients and staff, and a system that placed targets, finances and foundation trust status above acceptable standards of care. The same inquiry also found that the system as a whole failed in its essential duty to protect patients from unacceptable harm. That was not a local aberration. It was an exposure of institutional logic.

One consequence of this target-setting approach has been the routine importation of clinical labour to compensate for domestic workforce planning failure. The ethical problem is not that foreign clinicians come here; many have served patients with skill and dedication. The problem is that Britain has become structurally dependent on drawing trained people from abroad while failing to build a resilient domestic pipeline. The WHO’s safeguards exist precisely because poorer countries can be damaged when richer systems actively recruit from fragile health workforces. The government’s impact statement on medical training now recognises that UK-trained doctors have faced growing competition for training posts from overseas-trained applicants, with 15,723 UK-trained doctors and 25,257 overseas-trained doctors competing for 12,833 posts in 2025.

Population growth has also increased pressure on services. Estimates show long-term net migration reaching 944,000 in the year ending March 2023 and that overall net migration has increased by over 5 million people since 2010. The relationship between migration and NHS pressure is not crude: migrants also staff the NHS and many are younger and healthier than the native population. But additional population still creates additional demand, and the Nuffield Trust has previously estimated that EU migration added direct NHS costs while noting that this was small compared with wider pressures such as population ageing, technology and wages.

Most sickening of all is the return of patients dying before treatment. In February 2026, investigative journalists found 79,130 people had been removed from NHS waiting lists because patients had died before reaching treatment, including 7,737 who had waited more than a year before dying. The precise interpretation of those figures must be handled carefully: not every death on a waiting list is caused by the wait. But the moral fact remains. A system created to relieve suffering is now presiding over mass delay, prolonged pain and preventable death.

The human cost is measurable in other ways too. The UK performs poorly on avoidable mortality compared with peer countries, has below-average survival for many leading cancers, and has longstanding weaknesses in capital investment, beds, scanners and clinical staffingThe NHS faces an unprecedented financial and operational challenge, with rising demand, workforce and productivity problems, and a possible mismatch between demand and funding that will make service levels unacceptable unless something changes.

The NHS is in serious trouble. It cannot handle another government “fix”. It needs Restoration.

Learning from the Universal Health Framework

Alex Coppen’s Restorationist article on the “Universal Health Framework” is a serious and detailed attempt at replacement. I would urge any policy maker to read it for two reasons: it proves that alternatives to the existing NHS model can be imagined without abandoning universality, and the rest of this article will make a lot more sense if read against a worked alternative.

Read the original document here:

The British Universal Health Framework: A Gold Standard To Replace The NHS
Healthcare that compounds wealth for your grandchildren. Competition that ends waiting lists. Coverage that protects everyone absolutely. The Restorationist presents the Universal Health Framework: Singapore’s savings discipline with European choice. Britain’s third way.

The UHF’s core architecture is personal HealthVault savings accounts funded by compulsory contributions, employer top-ups, a not-for-profit “catastrophic” HealthGuard insurance fund, competing Health Foundations, wellness incentives, transparent pricing and strong safety nets. These pillars are largely absent from today’s NHS.

Several UHF principles should be adopted. The explicit distinction between lifestyle choices and unavoidable misfortune is morally sound: repeated behaviours such as smoking, excess alcohol consumption and sustained obesity should carry measurable personal consequences, while congenital conditions, random accidents and pure bad luck demand unconditional solidarity. Personal ownership of health spending below a catastrophic threshold creates real stewardship. Transparency on prices, outcomes and waiting times, competition between providers and wellness rewards would all shift the system toward personal accountability without abandoning universal protection.

However, the full UHF model is not the full answer. It is too complex. Its array of named funds, special programmes, risk-equalisation panels, quarterly checks, procurement rules and transition machinery risks building the very bureaucratic structure it seeks to replace. The reliance on overseas care as a safety valve may also recreate ethical and practical dependencies elsewhere. Replacing one administrative machine with another will only postpone decline.

Some elements also distract from the core health mission. Highly detailed rules around gender transition, addiction pathways and conscientious objection would import culture-war bureaucracy into a system that should be focused on timely treatment, prevention, safety, truth-telling and clinical excellence.

The proposed 15- to 20-year transition and 60% parliamentary supermajority requirement are politically unrealistic. But the proposal does raise a vital point: the future health system must be less exposed to constant government meddling. The NHS has suffered not only from under-capacity and poor planning, but from political reorganisation masquerading as reform that has failed for 78 years.

Most importantly, UHF underplays the deeper cultural task. Better incentives alone will not prevent new institutions from drifting toward self-preservation. A system can have elegant funding and still lose its soul.

Transformation, Not Another “Fix”

Genuine transformation must be bolder than incremental NHS patching and simpler than the full UHF blueprint. It should take the strongest principles from UHF: ownership, accountability, competition, transparency and the lifestyle distinction. It should reject unnecessary complexity, ideological accretions and a transition so long that it becomes a way of avoiding decision.

The centrepiece should be Personal Health Accounts: visible, inheritable savings seeded by compulsory but transparent contributions. Below a sensible annual threshold, age-adjusted and protected by exemptions, patients would spend their own money. Imagine opening an app for a painful knee. You see your live balance, transparent prices, verified reviews and real waiting times across competing local clinics and hospitals. You can book physiotherapy next week for one price or tomorrow for another. The psychological shift is immediate. You become a steward, not a passive consumer. There is now a benefit to you and society for being healthy.

For serious illness, accidents or conditions beyond anyone’s control, catastrophic coverage would activate automatically, with no lifetime limits. Competing mutual-style funds would handle this layer and be incentivised to deliver coordinated care because patients could switch annually. Lifestyle-related conditions would carry clear but limited consequences, determined by independent clinical panels using transparent and appealable criteria. Addiction and mental health would receive proper evidence-based support, but the system would stop pretending that all risks are identical. Congenital conditions, random cancers, trauma and disability from birth or misfortune would remain fully protected.

Provider networks should be smaller and more local than the UHF’s large entities, competing openly on quality, speed and outcomes. They should publish real data. Poor performers should lose patients and revenue. Clinical leadership should be restored. Managers should support clinicians, not direct them from a distance. Safety systems modelled on aviation should become mandatory, with learning from error valued instead of concealed.

Staffing reform must prioritise domestic training pipelines, better retention, better conditions and lower bureaucracy so clinicians spend more time with patients. International recruitment should become ethical, transparent and limited to genuine specialist need, not a permanent substitute for national workforce planning.

A streamlined, ring-fenced safety net should protect the poorest, veterans, children with rare or severe congenital conditions and those with disabilities unrelated to lifestyle. Emergency care and maternity should remain effectively free at the point of use. No-fault compensation for medical harm should replace the current litigation lottery.

Under such a system, competition, transparency, personal incentives and targeted safety nets would compress waits back toward the 18-week standard we once achieved, and ideally beyond it. The point would not be to game a target. The point would be to restore the timely relief of suffering as the organising purpose of the system.

This is not Americanisation. It is a British synthesis: universal coverage with real ownership; solidarity for the blameless with accountability for choices; competition without allowing profit extraction to dominate; and a smaller bureaucracy so resources flow toward clinicians and patients. The founding telos would become visible again in daily operations.

Restoring True British Healthcare

The NHS was one of humanity’s greatest ideas. Its founding purpose, to stand between people and unnecessary suffering, remains a principle worth fighting for. But the institution as it exists today has largely ceased to serve that purpose. Too often, it serves itself.

Real love for the founding ideal demands radical honesty about this failure. By adopting the strongest principles of personal ownership, accountability and competition while rejecting unnecessary complexity and cultural distraction, Britain can build a system that truly delivers on the original moral promise.

The British people deserve healthcare that honours both solidarity and responsibility. Anything less betrays the nobility of the vision that created the NHS.


Gary Walker served as Chief Executive of United Lincolnshire Hospitals NHS Trust from 2006-2010 and held multiple senior leadership roles across the NHS and Department of Health. He has since worked in regulation, international charity leadership, organisational turnaround, governance investigations, and has supported whistleblowers for over a decade.